Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.

Bhatt AS, Vaduganathan M, Claggett BL, Fonarow GC, Packer M, Pfeffer MA, Shah SJ, Shen X, Cristino J, McMurray JJV, Solomon SD, Gaziano TA

Open source

DOI: 10.1001/jamacardio.2023.3216
Published: 2023 Nov 1
Container: JAMA cardiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamacardio.2023.3216,
  title = {Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.},
  author = {Bhatt AS and Vaduganathan M and Claggett BL and Fonarow GC and Packer M and Pfeffer MA and Shah SJ and Shen X and Cristino J and McMurray JJV and Solomon SD and Gaziano TA},
  year = {2023},
  journal = {JAMA cardiology},
  doi = {10.1001/jamacardio.2023.3216},
  url = {https://doi.org/10.1001/jamacardio.2023.3216}
}

RIS

TY  - JOUR
TI  - Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.
AU  - Bhatt AS
AU  - Vaduganathan M
AU  - Claggett BL
AU  - Fonarow GC
AU  - Packer M
AU  - Pfeffer MA
AU  - Shah SJ
AU  - Shen X
AU  - Cristino J
AU  - McMurray JJV
AU  - Solomon SD
AU  - Gaziano TA
PY  - 2023
JO  - JAMA cardiology
DO  - 10.1001/jamacardio.2023.3216
UR  - https://doi.org/10.1001/jamacardio.2023.3216
ER  -

APA

AS, B., M, V., BL, C., GC, F., M, P., MA, P., SJ, S., X, S., J, C., JJV, M., SD, S., & TA, G. (2023). Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2023.3216

Source records

pubmed · retrieved 2026-09-26T21:22:08.827Z